Search
BioXcel Therapeutics Inc
BTAIAdd to Watchlist
1.370USD
-0.040-2.84%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
42.30MMarket Cap
LossP/E TTM
BioXcel Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
642.00K
-71.67%
EPS(YoY)
-5.73
98.48%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total revenue reached 642.00K, with a year-on-year change of -71.67.
What are the current assets of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its current assets were 44.69M, with a year-on-year change of 19.50.
What are the total assets of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total assets of BioXcel Therapeutics Inc were 44.92M, with a year-on-year change of 17.16.
What are the total liabilities of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total liabilities of BioXcel Therapeutics Inc were 140.38M, with a year-on-year change of 6.80.
What is the total equity of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its total equity of BioXcel Therapeutics Inc was -95.46M, with a year-on-year change of -2.54.
What is the net financing of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its net financing of BioXcel Therapeutics Inc was 56.52M, with a year-on-year change of 54.17.
What is the Earnings Per Share (EPS) of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.73, with a year-on-year change of 98.48.
What is the net margin of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its net profit margin was -10887.38, with a year-on-year change of -313.95.
What is the gross margin of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its gross margin was 74.45, with a year-on-year change of 1271.66.
What is the debt-to-asset ratio of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 244.00, with a year-on-year change of -8.74.
What is the Return on Assets (ROA) of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -167.91, with a year-on-year change of -57.83.
What is the operating profit of BioXcel Therapeutics Inc?
According to BioXcel Therapeutics Inc's FY2025 earnings report, its operating profit was -50.27M, with a year-on-year change of 22.43.